Recent data indicate that H19-derived miR-675 favours tumor progression by repressing the expression of several target genes, including Rb in colorectal cancer [12], Twist1 in hepatocellular carcinoma [18], and RUNX1 in gastric cancer [19]. The gene discussed is H19; the disease is gastric cancer.